Ascendis Pharma A/S (ASND) Q3 2019 Earnings Call Transcript
ASND earnings call for the period ending September 30, 2019.
Ascendis Pharma
ASND
ASND
$107.56
-$2.23
-2.0%
BATS BZX Real Time Price as of December 6, 2019, 4:00 p.m. EST
View Interactive ASND Charts
ASCENDIS PHARMA A/S ADR REPR ORD SHARES DKK1.00
News & Analysis: Ascendis Pharma
Ascendis Pharma A/S (ASND) Q2 2019 Earnings Call Transcript
ASND earnings call for the period ending June 30, 2019.
Ascendis Pharma A/S (ASND) Q4 2018 Earnings Conference Call Transcript
ASND earnings call for the period ending December 31, 2018.
Why Washington Real Estate Investment Trust, Ascendis Pharma, and Bluegreen Vacations Jumped Today
Find out how these stocks climbed in a down market.
Here's Why Ascendis Pharma Is Rocketing Higher Today
A proprietary extended-release drug-delivery technology may be worth a lot more than anyone expected.
Ascendis Pharma A/S (ASND) Q3 2018 Earnings Conference Call Transcript
ASND earnings call for the period ending September 30, 2018.
Ascendis Pharma (ASND) Q2 2018 Earnings Conference Call Transcript
ASND earnings call for the period ending June 30, 2018.
Why L Brands, Ascendis Pharma, and Phillips 66 Partners Jumped Today
These stocks climbed despite a mixed market. Find out why.
This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%
One biopharma's loss is another biopharma's gain when it comes to rare disease drug trials.
